CORT - Corcept Therapeutics GAAP EPS of $0.28 beats by $0.06 revenue of $123.6M beats by $3.88M
2023-11-01 16:28:19 ET
More on Corcept Therapeutics
- Corcept Therapeutics: Far More Constructive With Korlym Resolve (Rating Upgrade)
- Corcept Therapeutics Q3 2023 Earnings Preview
- Corcept Therapeutics plunges amid patent trial with Teva (update)
- Seeking Alpha’s Quant Rating on Corcept Therapeutics
- Historical earnings data for Corcept Therapeutics
For further details see:
Corcept Therapeutics GAAP EPS of $0.28 beats by $0.06, revenue of $123.6M beats by $3.88M